CS Paper Radar

A Scientific Claim Stability Framework for Evaluating MRI Morphometry Pipelines

Duy-Cat Can, Dang-Duat Tran, Anh-Khang Nguyen, Quoc-Bao Tran, Trung-Hieu Do, Van-Tu Nguyen, Duy-Thanh Vu, Oliver Y. Chén, Hoang-Quynh Le

cs.LG q-bio.QMstat.ME ·submitted 2026-11-02 02:35 UTC · v1
top venue

Abstract

MRI morphometry pipelines are often evaluated by measurement agreement or downstream accuracy, yet their scientific value depends on the conclusions they support. Two pipelines can produce similar feature-level results yet support different conclusions about aging, cognitive decline, or neurodegeneration. We introduce Scientific Claim Stability (SCS), a claim-centric evaluation framework that converts region-of-interest (ROI) morphometry tables into auditable claim cards and evaluates their support under changes in dataset, processing pipeline, atlas, feature family, and target. Across 10,370 MRI scans from three datasets and five cohorts, SCS generates 2,783 claim cards and evaluates 89 claim-family pairs. The evaluation distinguishes stable, transferable, and fragile claims. FreeSurfer 8-FastSurfer comparisons show high evidence concordance and low anatomical-support overlap under the primary covariate specification. Acquisition-adjusted analyses show that the magnitude of support disagreement depends on the model specification. Structured review by specialists in geriatrics, neuroscience, and radiology, alongside auxiliary ChatGPT and Gemini reviewers, assesses claim plausibility, clarity, faithfulness, usefulness, and caution. SCS provides a reproducible way to audit the evidential stability of morphometry claims without assuming a universal gold standard.

Comment
44 pages, 4 figures. Accepted at NeurIPS 2026 (Evaluations and Datasets Track)

Closest papers

Nearest neighbours by meaning across the whole index.

OpenBrain: An Auditable Generated-Label Release for Whole-Brain MRI Parcellation

cs.CV ·2026-11-03 ·Qizhen Lan, Yu-Chun Hsu, Yuxiang Wei, Lijing Zhu, Zenan Sun +3 more
top venuecode/data similarity 0.62
Abstract · Accepted at NeurIPS 2026, Evaluations and Datasets Track. Dataset: https://huggingface.co/datasets/lanqz7766/OpenBrain; code: https://github…

Automatic tools can now generate whole-brain MRI parcellations at cohort scale, but generated-label releases often provide little evidence about which cases are reliable enough to reuse. We introduce OpenBrain, a confidence-aware release of 35,838 provenance-verified OpenNeuro T1w cases from 607 source datasets. OpenBrain is organized as an auditable case-record release rather than a directory of standalone segmentation files: each record links a primary parcellation, two committee parcellations, source/license provenance, raw QC-7 measurements, percentile risks, a combined risk score R, and a confidence tier. QC-7 is a reference-free reliability panel over label geometry, image-label consistency, and committee disagreement, so users can filter, weight, audit, or re-threshold generated labels without rerunning inference. We evaluate this released evidence under a frozen protocol. Across external cohorts, lower QC-7 risk corresponds to higher generated-label quality; in fixed-budget training, lower-risk selections improve paired macro Dice over random selection by +3.2 to +3.7 percentage points. OpenBrain also exposes raw axes, committee outputs, provenance, and datasheet documentation, so confidence claims remain inspectable after download. It does not turn generated labels into manual annotations or clinical-grade segmentations. Its contribution is a large open generated-parcellation substrate, a reusable case-level risk-evidence layer, and an external validation protocol for release-time QC. Dataset: https://huggingface.co/datasets/lanqz7766/OpenBrain. Code: https://github.com/lanqz7766/openbrain.

0.44

Evidence-Bound Reasoning: Neuro-Semantic Verification of Biomedical AI in Glioblastoma Radiogenomics

cs.CL ·2026-10-06 ·Mariya Miteva, Maria Nisheva-Pavlova
benchmark similarity 0.62
Abstract · 15 pages, 4 figures, 4 tables. Preprint

Background: Biomedical AI can generate plausible explanations without reliably verifying whether each statement is supported by patient-specific evidence. We developed a neuro-semantic verification framework that converts radiomic measurements into addressable evidence records and machine-checkable claims. Methods: UPenn-GBM radiomics were aligned with de novo CaPTk extraction from standardized MRI and expert-validated segmentations in an independent multicenter cohort. The shared space comprised 1,728 features from T1, T1GD, T2, and FLAIR MRI across three tumor regions. Reference-defined semantic states were derived from 611 UPenn cases. We evaluated cross-cohort transportability, model-linked provenance, deterministic verification, controlled predictive degradation, and an LLM claim-extraction pilot; MGMT prediction served only as a transport stress test. Results: Median semantic-state agreement was 0.786 (weighted kappa 0.709), ranging from 0.918 for morphologic to 0.252 for intensity features. The external evidence ledger contained 1,655 model-linked records for 331 patients. The verifier achieved 100% exact-set accuracy in a 6,620-claim corruption benchmark. In a 24-case pilot, GPT-5.6 Sol reproduced 72/72 prespecified atomic claims, and the frozen verifier recovered 24/24 expected conditions. During controlled degradation, ROC AUC declined from 0.899 to 0.500 while verification accuracy remained 1.000. External MGMT discrimination was weak (ROC AUC 0.543). Conclusions: Verifiability can be engineered and evaluated independently of predictive performance. LLMs may structure explanations, while final evidence-consistency checking remains deterministic.

0.23

BrainTRACE: Tracing Longitudinal, Multimodal, and Volumetric Evidence in Brain MRI Clinical Reasoning

cs.CV cs.AI ·2026-10-05 ·Qizhen Lan, Mengchen Fan, Hang Zhang, Jingwei Duan, Moule Lin +3 more
top venuebenchmark similarity 0.62
Abstract · 35 pages. Accepted to NeurIPS 2026

Brain MRI interpretation is a longitudinal clinical reasoning problem: radiologists compare serial studies, integrate information across MRI sequences, localize findings within volumetric anatomy, and translate this evidence into report-grounded assessments. Existing medical VQA and 3D imaging benchmarks capture important parts of this workflow, but often evaluate brain MRI through isolated images, static volumes, or ungrounded report-style answers, thereby obscuring failures in the evidence chain that support clinical validity. We introduce BrainTRACE, a report-grounded benchmark for evaluating whether vision-language models can trace the evidence structure required for longitudinal brain MRI interpretation. BrainTRACE contains 7,273 scored VQA instances derived from 1,778 longitudinal patients, 7,299 MRI studies, and approximately 29k co-registered 3D MRI sequence volumes. The benchmark is organized by five levels of clinical reasoning, from acquisition recognition to case-level synthesis, and by evidence demands covering longitudinal comparison, report-grounded references, multi-sequence integration, and volumetric spatial evidence. BrainTRACE supports rendered inputs compatible with standard VLM interfaces, a 3D-evidence condition, and a decomposed case-reasoning track that audits six steps in a longitudinal evidence chain. Evaluation of 20 VLM configurations shows that current systems can identify isolated visual cues but rarely compose them into grounded longitudinal interpretations. We release the benchmark specification, evaluation lists, scoring implementation, scoring rubrics, and audit-record format to support reproducible progress in brain MRI VLM evaluation.

0.48

Resampling-based batch reweighting for ComBat harmonization of MRI radiomic features in a multi-scanner glioma cohort

eess.IV physics.med-ph ·2026-11-01 ·Rifa Sajda Tasnim, Yushuf Sharker, Md Forhad Hossain, Rakibur Rahman, Enamul Hoque Bhuiyan
published similarity 0.60
Abstract · Original article. Submitted to Journal of Magnetic Resonance Imaging (JMRI)

Radiomic features derived from magnetic resonance imaging (MRI) are sensitive to scanners; therefore, they require harmonization across scanners. In a radiomic feature dataset, some batches may be severely underrepresented compared to the others e.g., the Erasmus Glioma Database, which may provide harmonized features biased towards the larger batches in the dataset. We investigated whether reweighting underrepresented scanner batches before empirical-Bayes ComBat estimation improves feature harmonization and reduces residual scanner association while retaining grade-related information. In this retrospective, the Erasmus Glioma Database included 733 eligible patients acquired at a single center across nine vendor-by-field-strength configurations. Structural MRI acquired at 1 T, 1.5 T, and 3 T; four structural MRI sequences were analyzed. From four structural MRI sequences, 428 features were computed using an IBSI-compliant PyRadiomics implementation. The sample sizes of some scanner batches were very small compared to others, which may produce unequal precision and shrinkage of batch-effect estimates. We proposed a data augmentation approach to overcome the limitation of ComBat. We provided exploratory evidence, along with confirmatory Kruskal-Wallis tests with a Benjamini-Hochberg correction to assess the proposed method. Before harmonization, 392/428 features (91.6%) differed significantly across scanner batches (median eta-squared=0.463). Standard ComBat reduced this to 13/428 (3.0%), whereas batch-augmented ComBat reduced it to 8/428 (1.9%); the median residual effect size was <0.001 for both harmonized conditions. Batch augmentation appeared to be a useful strategy to improve the performance of ComBat for feature harmonization under severe batch-size imbalance.

0.32

Evaluating the Safety of Deep Learning-Based Brain MRI Reconstruction

eess.IV cs.CV ·2026-08-28 ·Dat Tat Mai, Thai Viet Pham, Thu Nguyen Thi Dang, James Jin Kang
similarity 0.59
Abstract

Objective: Deep learning accelerates brain MRI four- to tenfold, but models can erase lesions or synthesize false tissue - failures pixel-averaged metrics like PSNR and SSIM miss. We review whether current evaluation practices detect this blind spot. Methods: Following PRISMA 2020, we searched seven databases without date limits, including 263 studies (1995-2026), appraised them using QUADAS-2 and matched instruments, and synthesized narratively. Categories were derived from titles, abstracts, and controlled vocabulary; reported prevalence figures represent floors. Duplicate screening achieved high agreement (Fleiss kappa = 0.877), as did appraisal (0.788; 0.390 where observable). Extraction is unaudited. Results: Only 18 of 263 studies (6.8%) recorded both a fidelity metric and reader assessment on identical data, leaving the central surrogate unmeasured. Reader studies mostly measured inter-reader agreement, which was weak: fastMRI 2020 concordance reached 0.457 and 0.386 (Kendall W), improving only where SSIM diverged. Erasing a 100 mm3 lacunar infarct shifts global PSNR by 0.03 dB under the stated error model. As the corpus grew fivefold, reader assessments dropped from 32% to 18%, recovering to 21%. Generative models - most associated with hallucination (39%) - were among the least reader-evaluated (11.3%), while self-supervised models reached 47% with zero reader evaluation. Only 5% released code and ran reader studies; none evaluated a model observer; no named dataset covered acute stroke or hemorrhage. Conclusions: On these floors, current evaluation practices cannot certify diagnostic safety. We derive five requirements safety-oriented evaluations must meet.

0.21

BrainDiff: Longitudinal Report Generation for Multimodal Brain MRI

cs.CV ·2026-09-01 ·Krish Patel, Peirong Liu
code/data similarity 0.58
Abstract · 13 pages, 3 figures

Neuroradiologists rarely read a brain MRI in isolation, yet automated brain-MRI report generation has been built almost entirely for single studies. Temporal analysis has been explored on chest radiography and chest CT, but to our knowledge, longitudinal reporting for brain MRI, where interval change is often subtle and spatially distributed, remains unaddressed. We present BrainDiff, the first longitudinal vision-language system for brain MRI. BrainDiff outperforms both frontier general-purpose and single-study neuroimaging models on the same patient pairs. Moreover, BrainDiff retains 91% of internal RadGraph-XL entity+relation F1 (rg_er) on an external, cross-hospital cohort. Beyond the system, we contribute three analyses. First, we identify two independent grounding levers: a counterfactual objective with prior-report dropout, which increases measured image reliance by ~47%, and a staged curriculum. Together, these interventions raise image reliance 2.5-fold from the baseline. Second, we provide a factorial over prior-report availability and image identity, isolating a visual contribution of +0.0387 rg_er, which grows when the prior report is withheld. Third, a cheap change-decodability test for candidate backbones shows that interval change is decodable far more weakly than single-study pathology (0.60 vs. 0.77 AUROC). Code is publicly available at https://github.com/jhuldr/BrainDiff.

0.45

How Good are Foundation Models in Longitudinal MRI Disease Progression Reasoning?

cs.CV ·2026-08-13 ·Wafa Al Ghallabi, Ritesh Thawkar, Sara Ghaboura, Omkar Thawakar, Numan Saeed +4 more
top venuebenchmarkcode/data similarity 0.58
Abstract · Accepted at MICCAI 2026 (Early Accept). 11 pages, 3 figures, 2 tables

Magnetic Resonance Imaging (MRI) interpretation is fundamental to clinical decision-making, requiring radiologists to integrate multi-view anatomical planes across sequential timepoints while precisely localizing interval changes. However, existing vision-language benchmarks remain confined to single-timepoint, single-view interpretation, failing to capture the temporal-spatial reasoning essential to radiologic practice. We introduce the Time-Aware Multi-View MRI Benchmark, an evaluation framework unifying multi-view anatomical input, temporal reasoning across longitudinal scans, and structured localization guidance. The benchmark comprises 3,920 expert-verified question-answer pairs derived from 890 patients across over 3,200 longitudinal MRI timepoints, drawn from seven clinical cohorts covering glioblastoma, neurodegeneration, vestibular schwannoma, and brain metastases, in open-ended, multiple-choice, and binary formats, requiring models to identify anatomical regions of maximal change, characterize progression across sequences and views, and provide structured guidance specifying boundaries, imaging features, and confounders. Experiments across 16 vision-language models reveal moderate temporal alignment but systematic failure on change direction recognition and volumetric quantification, while multi-view inputs improve spatial localization yet degrade temporal reasoning in compact architectures. Our benchmark provides a systematic framework for evaluating progression tracking, interval change localization, and temporal ordering, which are essential for clinical deployment. Code, evaluation splits, and the dataset are available at: https://github.com/wafaAlghallabi/Time-Aware-MRI.

0.56

A Vision-Language Foundation Model for Precise and Comprehensive Brain Tumor Diagnosis from Preoperative Multimodal Data

cs.CV cs.AI ·2026-09-15 ·Yinong Wang, Jianwen Chen, Zhou Chen, Shuwen Kuang, Haoning Jiang +26 more
code/data similarity 0.56
Abstract · 94 pages, 22 Figures, supplement files, Project page link: https://hku-healthai.github.io/brainvlm_project.github.io/

We developed BrainVLM to classify all 12 World Health Organization (WHO) 2021 brain tumor types. BrainVLM integrates an uncertainty quantification strategy to indicate prediction reliability and a module for generating radiology reports to elucidate the clinical rationale. BrainVLM was trained on multi-modal data (MRI scans, demographics, and radiology reports) from 40,043 individuals. It was validated on 5,211 patients with pathologically confirmed brain tumors, including 3,877 held-out patients from the primary hospital and 1,334 patients from 11 independent hospitals. We further conducted two proof-of-concept studies to validate its clinical utility in AI-clinician workflows: 1) a blinded multireader study where 12 neuroradiologists across varying experience levels interpreted 248 retrospective cases with or without AI assistance, and 2) a real-world prospective study in which 1,009 patients were independently and blindly assessed by BrainVLM and radiologists before surgery. Additionally, we demonstrated BrainVLM's utility in preoperative molecular subgroup prediction for adult-type diffuse gliomas, using a multi-center cohort of 632 patients. In primary evaluation, BrainVLM achieved an area under the curve (macro-AUC) of 0.85 (95% CI: 0.84-0.86), and an F1 score of 0.82 (95% CI: 0.81-0.83), surpassing neuroradiologists (F1 = 0.80 (95% CI: 0.79-0.81)). In external validation across 11 centers, BrainVLM achieved an AUC = 0.80 (95% CI: 0.79-0.82) and F1 = 0.75 (95% CI: 0.73-0.78), compared with F1 = 0.71 (95% CI: 0.69-0.73) for neuroradiologists. In prospective real-world evaluation, BrainVLM maintained performance comparable to neuroradiologists. The BrainVLM project page is available at https://hku-healthai.github.io/brainvlm_project.github.io/.

0.35